Cargando…
Clinical Potential of Hydrogen Sulfide in Peripheral Arterial Disease
Peripheral artery disease (PAD) affects more than 230 million people worldwide. PAD patients suffer from reduced quality of life and are at increased risk of vascular complications and all-cause mortality. Despite its prevalence, impact on quality of life and poor long-term clinical outcomes, PAD re...
Autores principales: | Bechelli, Clémence, Macabrey, Diane, Deglise, Sebastien, Allagnat, Florent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297923/ https://www.ncbi.nlm.nih.gov/pubmed/37373103 http://dx.doi.org/10.3390/ijms24129955 |
Ejemplares similares
-
Clinical Use of Hydrogen Sulfide to Protect Against Intimal Hyperplasia
por: Macabrey, Diane, et al.
Publicado: (2022) -
Sodium thiosulfate, a source of hydrogen sulfide, stimulates endothelial cell proliferation and neovascularization
por: Macabrey, Diane, et al.
Publicado: (2022) -
Sodium thiosulfate acts as a hydrogen sulfide mimetic to prevent intimal hyperplasia via inhibition of tubulin polymerisation
por: Macabrey, Diane, et al.
Publicado: (2022) -
Vascular smooth muscle cells in intimal hyperplasia, an update
por: Déglise, Sébastien, et al.
Publicado: (2023) -
Cystathionine-γ-lyase overexpression modulates oxidized nicotinamide adenine dinucleotide biosynthesis and enhances neovascularization
por: Kiesworo, Kevin, et al.
Publicado: (2023)